1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anticoagulants Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Novel Oral Anticoagulants (NOACs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Heparin and Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Vitamin K Antagonist
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral Anticoagulant
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Injectable Anticoagulant
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Application
9.1 Atrial Fibrillation and Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Alexion Pharmaceuticals Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Aspen Holdings
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Boehringer Ingelheim International GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Daiichi Sankyo Company Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Dr. Reddy’s Laboratories Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Johnson & Johnson Private Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2023
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2023
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: North America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: United States: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: China: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: India: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: France: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2023
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players